Skip to main content
. 2017 May 14;2017:1797512. doi: 10.1155/2017/1797512

Table 1.

Subject characteristics.

Exposed Unexposed
No fibrosis Asbestosis Healthy controls
N 66 19 28
Age (years) 64.5 (6.2) 68.5 (6.0) p = 0.015 62.2 (6.6)
Time since the beginning of the exposure (years) 43.6 (0.9) 46.2 (3.4) p = 0.464
FVC (% pred) 88.8 (15.6) 83.7 (10.8) p = 0.194 99.5 (10.8)
FEV1 (% pred) 88.5 (14.2) 81.8 (12.0) p = 0.071 96.7 (11.6)
D L,CO (% pred) 106.4 (17.4) 87.1 (16.8) p < 0.001 N.A.
IL-6 (pg/ml) 3.2 (2.4–4.3) 3.2 (2.0–5.0) p = 0.728 2.1 (1.6–2.8)
CRP (μg/ml) 0.93 (0.37–1.99 1.20 (0.60–2.94) p = 0.282 0.47 (0.27–1.00)
Adipsin (ng/ml) 893 (777–1069) 1022 (950–1224) p = 0.004 908 (757–1045)
MMP-9 (ng/ml) 28.1 (22.4–36.9) 54.7 (32.8–70.9) p < 0.001 30.3 (25.4–38.9)

Values are presented as mean (SD) or median (IQR) when appropriate according to the distribution of variables. FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; DL,CO: diffusing capacity for carbon monoxide; IL-6: interleukin 6; CRP: C-reactive protein; MMP-9: matrix metalloproteinase-9; N.A: not assessed. p values were calculated between asbestos-exposed subjects without fibrosis and asbestos-exposed subjects with asbestosis using unpaired t-test or Mann–Whitney U test when appropriate.